| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 31.245 | 87.275 | 122.396 | 203.844 | 153.019 | 169.906 | 222.407 | 206.835 | 143.245 |
| Total Income - EUR | - | 31.245 | 87.276 | 122.749 | 204.839 | 153.708 | 170.322 | 235.962 | 206.927 | 143.286 |
| Total Expenses - EUR | - | 27.808 | 68.340 | 108.281 | 155.467 | 126.997 | 147.056 | 197.514 | 182.482 | 159.266 |
| Gross Profit/Loss - EUR | - | 3.436 | 18.936 | 14.468 | 49.372 | 26.710 | 23.266 | 38.449 | 24.445 | -15.980 |
| Net Profit/Loss - EUR | - | 2.499 | 16.317 | 13.308 | 47.470 | 25.286 | 21.703 | 36.150 | 22.687 | -19.034 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bionson Diagnostic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 22 | 713 | 4.400 | 19.802 | 21.117 | 16.037 | 14.725 | 10.051 | 7.569 |
| Current Assets | - | 12.451 | 67.932 | 85.473 | 138.055 | 142.704 | 146.761 | 211.691 | 166.143 | 130.535 |
| Inventories | - | 43 | 3.171 | 20.676 | 31.740 | 39.896 | 51.335 | 71.696 | 54.509 | 55.043 |
| Receivables | - | 8.011 | 48.937 | 63.979 | 94.317 | 91.527 | 85.624 | 111.110 | 97.738 | 71.396 |
| Cash | - | 4.397 | 15.824 | 818 | 11.998 | 11.281 | 9.802 | 28.885 | 13.896 | 4.096 |
| Shareholders Funds | - | 2.543 | 16.370 | 24.854 | 68.335 | 77.234 | 77.025 | 78.775 | 101.223 | 75.286 |
| Social Capital | - | 45 | 44 | 43 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 9.948 | 52.292 | 65.187 | 89.668 | 86.743 | 85.961 | 147.915 | 75.405 | 63.266 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Bionson Diagnostic Srl